390 related articles for article (PubMed ID: 7562769)
1. Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit.
Arner EC; Harris RR; DiMeo TM; Collins RC; Galbraith W
J Rheumatol; 1995 Jul; 22(7):1338-46. PubMed ID: 7562769
[TBL] [Abstract][Full Text] [Related]
2. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit.
Lewthwaite J; Blake SM; Hardingham TE; Warden PJ; Henderson B
J Rheumatol; 1994 Mar; 21(3):467-72. PubMed ID: 8006890
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention.
Bell MC; Carroll GJ
J Rheumatol; 2000 Feb; 27(2):332-8. PubMed ID: 10685793
[TBL] [Abstract][Full Text] [Related]
4. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
[TBL] [Abstract][Full Text] [Related]
5. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation.
Dingle JT; Page Thomas DP; Hazleman B
Int J Tissue React; 1987; 9(4):349-54. PubMed ID: 3497901
[TBL] [Abstract][Full Text] [Related]
6. Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures.
Jikko A; Wakisaka T; Iwamoto M; Hiranuma H; Kato Y; Maeda T; Fujishita M; Fuchihata H
Cell Biol Int; 1998; 22(9-10):615-21. PubMed ID: 10452831
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis.
van Meurs JB; van Lent PL; Singer II; Bayne EK; van de Loo FA; van den Berg WB
Arthritis Rheum; 1998 Apr; 41(4):647-56. PubMed ID: 9550473
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
9. Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage.
Sui Y; Lee JH; DiMicco MA; Vanderploeg EJ; Blake SM; Hung HH; Plaas AH; James IE; Song XY; Lark MW; Grodzinsky AJ
Arthritis Rheum; 2009 Oct; 60(10):2985-96. PubMed ID: 19790045
[TBL] [Abstract][Full Text] [Related]
10. [Suppression of articular cartilage breakdown in osteoarthritis by interleukin-1 receptor antagonist using ex vivo gene therapy].
Guo WS; Ma L; Li ZR
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):853-6. PubMed ID: 15200893
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
[TBL] [Abstract][Full Text] [Related]
12. Central role of the MEK/ERK MAP kinase pathway in a mouse model of rheumatoid arthritis: potential proinflammatory mechanisms.
Thiel MJ; Schaefer CJ; Lesch ME; Mobley JL; Dudley DT; Tecle H; Barrett SD; Schrier DJ; Flory CM
Arthritis Rheum; 2007 Oct; 56(10):3347-57. PubMed ID: 17907188
[TBL] [Abstract][Full Text] [Related]
13. Effect of animal age and chronicity of interleukin-1 exposure on cartilage proteoglycan depletion in vivo.
Arner EC
J Orthop Res; 1994 May; 12(3):321-30. PubMed ID: 8207585
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A
Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183
[TBL] [Abstract][Full Text] [Related]
15. Effects of growth factors and cytokines on proteoglycan turnover in articular cartilage.
Hardingham TE; Bayliss MT; Rayan V; Noble DP
Br J Rheumatol; 1992; 31 Suppl 1():1-6. PubMed ID: 1532522
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
17. Loading-induced changes in synovial fluid affect cartilage metabolism.
van de Lest CH; van den Hoogen BM; van Weeren PR
Biorheology; 2000; 37(1-2):45-55. PubMed ID: 10912177
[TBL] [Abstract][Full Text] [Related]
18. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
[TBL] [Abstract][Full Text] [Related]
19. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
20. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]